Background: Chronic kidney disease (CKD) is a frequent and serious complication of cardiac surgery. This study was designed to establish a scoring system, calculated in the immediate postoperative period, to assess the risk of CKD at 1 yr in patients undergoing cardiac surgery with cardiopulmonary bypass. Methods: We conducted a cohort study including patients with preoperative estimated glomerular filtration rate above 60 ml min À1 (1.73 m) À2 who underwent cardiac surgery with cardiopulmonary bypass. We identified risk factors for de novo
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Editor's key points
The risk of developing chronic kidney disease is high after cardiac surgery. Using data from large cohorts, the investigators developed a practical early postoperative score to predict de novo chronic kidney disease 1 yr after cardiac surgery. The components of the risk score are age >65 (1 point), low preoperative glomerular filtration rate (1 point), transplantation or aortic surgery (2 points), aortic clamping time >50 min (1 point), and postoperative acute kidney injury (1 or 2 points). With >3 points, the risk of chronic kidney disease at 1 yr is >50%.
Acute kidney injury (AKI) is a frequent complication of cardiac surgery. Depending on the definition and population, its incidence ranges from 15% to 45%. 1e4 The long-term implications, especially with regard to chronic kidney disease (CKD) progression, are now well established. 5e8 For example, Ryd en and colleagues 9 reported an incidence rate of up to 13/1000 patient years for de novo end-stage renal disease requiring dialysis in patients experiencing AKI stage 2 or 3 after primary coronary artery bypass graft (CABG), whereas it is only 1.7/1000 patient years in the general population. 10 In a previous study, we estimated that, in patients with reversible AKI, the hazard ratio for developing CKD in the following year was 2.3 when compared with patients similarly treated and matched for all known risk factors of AKI, but free from AKI itself (incidence rate: 15.7 vs 5.1 per 100 person years). 11 CKD is a major concern, particularly after cardiac surgery, because it increases cardiovascular morbidity and mortality, and because there is no cure for the disease. Recent strategies focusing on AKI prevention or treatment have shown disappointing results.
12e15
CKD is an indolent process. AKI occurring at the time of cardiac surgery could trigger mechanisms promoting the progression from acute kidney disease to CKD, a biological sequence now called 'maladaptive repair'. 16 Data from experimental studies have highlighted several mechanisms involved in this transition, such as the switch from fatty acid oxidation to glycolysis, 17 the G2/M cell cycle arrest, 18 or an epigenetic reprogramming of myofibroblasts. 19 This points to the rationale for developing a scoring system to identify patients in need of regular renal function monitoring, who could ideally receive a therapeutic intervention to prevent such a 'maladaptive repair', with resultant transition from AKI to CKD. Predictive scores for postoperative AKI are available, 20e22 but their usefulness is limited because there is no effective preventive or curative therapy. To our knowledge, there is no score in the literature that can predict the risk of developing CKD after AKI after cardiac surgery. Improving the risk assessment of the evolution towards CKD after cardiac surgery would have three consequences. First, by identifying modifiable risk factors, physicians would be in a better position to decrease the incidence of CKD after cardiovascular procedures. Second, a high performance score could increase the diagnostic rate of indolent CKD after AKI, and might lead to specialised care, which has probable clinical benefits in terms of all-cause mortality, as shown in a population of patients with a recent (<90 days) history of severe AKI. 23 Third, it would facilitate the design of interventional trials aimed at reducing maladaptive repair of the renal epithelium in the aftermath of an ischaemic episode of AKI.
Here, we used a logistic multivariable regression model in an initial cohort of patients undergoing cardiac surgery to construct a score that was easy to use at the bedside and predictive for the occurrence of CKD at 1 yr post-procedure, which we then validated in a second independent cohort.
Methods

Study design
We conducted a two-centre retrospective cohort study at two French university hospitals (Caen and Bichat) where 500 to 1500 cardiac surgical procedures are performed every year. Patients from September 2005 to December 2016 were included. The inclusion criteria were cardiac surgery and age !18 yr. The exclusion criteria were the presence of CKD at the time of surgery [i.e. baseline estimated glomerular filtration rate (eGFR) <60 ml min À1 (1.73 m) À2 ] and absence of follow-up during the first year after surgery.
Definitions
Estimated glomerular filtration rate
Serum creatinine concentrations were measured using the Jaff e method in both hospitals. GFR was estimated (eGFR) using the Modification of Diet in Renal Disease (MDRD) creatinine equation. 24 When the test was isotope-dilution mass-spectrometry standardised, a correction was applied to the MDRD equation. 25 Baseline eGFR was calculated using the serum creatinine sampled during the anaesthesia consultation.
Acute kidney injury
For each patient, we calculated the shift of serum creatinine values in the first 7 days after surgery. The AKI group was staged according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. 26 Stage 1 AKI was defined as a 1. 
Main outcome
The main outcome was the occurrence of de novo CKD 1 yr after cardiac surgery. CKD is defined as at least two eGFR values 60 ml min À1 (1.73 m) À2 separated by an interval of at least 90 days according to the KDIGO guidelines 27 and measured during the first 12 months after the procedure.
Data sources
The study was completed using two independent blinded databases from each hospital, prospectively filled by clinical research associates. These databases were automatically updated with all serum creatinine measured onsite in each patient's serum during the study period. All data were anonymised and analysed in a blinded manner. As required by the French law, these two databases were officially reported to the Commission nationale de l'informatique et des libert es, the French data protection authority. The following variables were recorded:
(i) Clinical data: age at surgery, BMI, left ventricular ejection fraction (LVEF), cardiovascular risk factors (smoking, diabetes mellitus, chronic hypertension, and dyslipidaemia), prior history of heart failure, obstructive arterial disease, coronary heart disease, endocarditis, cirrhosis, neoplasia, or chronic obstructive pulmonary disease The risk score was derived from the database from the hospital containing the larger number of variables. The score was validated using data from the other hospital.
Statistical analyses
Continuous variables for individuals with and without CKD were expressed as mean (standard deviation) or as median (25the75th percentile) for non-normally distributed variables, or number and percentage. They were compared by Student's t-or ManneWhitney test.
Categorical variables were expressed as absolute and relative (%) frequency, and were compared by c 2 or Fisher's exact test, whenever appropriate.
In the multivariable analysis, results were expressed using odds ratios (ORs) and 95% confidence intervals (CIs).
To ensure our score was easy to calculate mentally, we dichotomised all non-binary variables. The optimal cut point was chosen according to ROC01 procedures, minimising the distance between the receiver operating characteristic (ROC) plot and the upper-left corner of the unit square. 28 Missing values were managed depending on how frequently they were missing (shown in Supplementary Fig. S1 and Supplementary Table S1 ). Variables with missing values above 5% were imputed 50 times by chained equations, whereas those with missing values below 5% were analysed in complete cases. 29 Variables with a univariate P-value <0.5 were first considered in the multivariable analysis, as well as clinically pertinent interaction between variables, and the final regression model was performed using modified backward selection. 30 Absence of multicollinearity was checked against a correlation matrix (Supplementary Fig. S2 ) and an analysis of the variance inflation factor. 31 The score was built by attributing to each variable a coefficient equal to its coefficient in the final logistic model rounding to the closest integer. The final score was submitted to the HosmereLemeshow goodness-offit test for calibration and by analysis of the area under the ROC curve (AUC) for discrimination. Internal validation was assessed by optimism-adjusted measure of AUC calculated by bootstrap and external validation by the independent cohort data set. 32 The methodology used for score development was similar to previous studies addressing AKI prediction.
20e22 Sensitivity analyses were performed to assess the risks of (i) selection bias attributable to loss of follow-up using calibrationweighting regression 33 and (ii) threshold effect by changing the main outcome to a relative 25% decrease in the eGFR. A P-value of <0.05 was considered significant, and all Pvalues were two tailed. Statistical analyses were performed using R software and packages pedometrics, 34 polycor, 35 corrplot, 36 survival, 37 ROCR, 38 PredictABEL, 39 rms, 40 mice, 41 VIM, 42 Icarus, 43 and ResourceSelection. 44 
Results
Derivation sample
From September 2005 to December 2016, 2398 patients undergoing cardiac surgery in Bichat Hospital were screened. We excluded 913 (38%) patients because they had preoperative eGFR below 60 ml min À1 (1.73 m) À2 , and 963 (40%) because of an insufficient follow-up. The patients' preoperative characteristics are shown in Table 1 . The comparative baseline characteristics between included patients and excluded for insufficient follow-up patients are shown in Supplementary  Table S2 . The score was built from the 522 remaining patients ( Supplementary Fig. S3 ). One year after surgery, 94 (18%) patients from the derivation cohort had developed de novo CKD. When compared with patients remaining CKD free at 1 yr, CKD patients were older (68 vs 62 yr; P<0.001) with a lower preoperative eGFR (72 vs 82 ml min À1 (1.73 m)
À2
; P<0.001), higher BMI (27 vs 26 kg m À2 ; P¼0.02), and higher EuroSCORE (6.6 vs 3.4; P<0.001). There were more smokers (58% vs 39%; P<0.001) and more hypertensive patients (71% vs 50%; P<0.001). During the surgical procedure, the median CPB and aortic clamping time were longer in the future CKD group (respectively, 76 vs 61 min; P<0.001 and 57 vs 47 min; P<0.001), and they received more transfusions (67% vs 30%; P<0.001) and more norepinephrine (4% vs 0%; P<0.001), and had more circulatory arrest (5.3% vs 1.4%; P¼0.02). With respect to the type of procedure, heart transplantation and aortic surgery were more common in these patients (20% vs 3.5%; P<0.001). The incidence of postoperative AKI was higher in the future CKD group (56% vs 22%; P<0.001), as shown in Supplementary Table S3 . total length of surgery, 50 min of aortic clamping time, 65 min of CPB time, 4 days of length of ICU stay, and 800 ml of total blood loss (ROC curves and sensitivity and specificity associated with cut-off value are shown in Supplementary Fig. S4 ).
Dichotomisation of continuous variables
Score derivation
The variables selected in the multivariable model were occurrence of AKI KDIGO stage 1 or higher, age >65 yr, BMI >30 kg m À2 , preoperative eGFR <80 ml min À1 (1.73 m) À2 , clamping time >50 min, blood transfusion, use of norepinephrine during surgery, and aortic or transplantation surgery. The OR for developing CKD and respective P-values or 95% CIs are presented in Figure 1 . For the sake of simplicity, we eventually excluded the use of norepinephrine or blood transfusion, and BMI variables because they did not improve the score discrimination (AUC from 0.84 with all variables to 0.81; P¼0.5).
The predictive risk of CKD was calculated according to the score presented in Table 2 , ranging from 0 to 7. The calibration analysis did not demonstrate a difference between observed and predicted risks (HosmereLemeshow c 2 goodness-of-fit test; P¼0.9; Supplementary Fig. S5 ). Figure 2 and Table 3 show the predicted and observed relative incidence ratios of CKD according to the score. The discrimination of the score in the derivation cohort for the prediction of CKD de novo was good, with an AUC of 0.81 (95% CI: 0.77e0.86; see Fig. 3 ), and there was no difference for optimism-adjusted AUC (0.80).
Validation of the score using an external cohort
The score was validated in a second independent cohort recorded at the other centre in Caen. Here, amongst the 2557 patients who underwent cardiac surgery during the study period, 680 (27%) had a preoperative eGFR <60 ml min À1 (1.73 m) À2 and 1441 (56%) had insufficient follow-up. They were similarly excluded. A total of 446 patients were used for validation ( Supplementary Fig. S6 ). The patient mean age was 66 (14) yr, mean BMI was 27.2 (5.2) kg m À2 , and median EuroSCORE was 5.5 (2.9e9.6), with a male sex prevalence of 74%. The mean preoperative eGFR was 87 (25) ml min À1 (1.73 m)
À2
, and 146 (33%) patients developed AKI after the surgical procedure. At 1 yr, 101 (23%) patients had developed de novo CKD. The differences between the derivation and validation samples are shown in Supplementary Table S4 .
The score calibration remained good in this population (HosmereLemeshow c 2 goodness-of-fit test; P¼0.1; Supplementary Fig. S7 ). Again, the score presented fair discrimination with an AUC ROC of 0.78 (95% CI: 0.72e0.83) (Fig. 3 ) that did not significantly differ from the AUC ROC of the derivation sample (P¼0.3). The predicted risks of CKD and associated 95% CIs for each score value are presented in Figure 3 and Supplementary Table S3 , with associated sensitivities and specificities.
Sensitivity analyses
The KDIGO CKD definition could induce a threshold effect. We, therefore, assessed our score considering a 25% relative reduction in eGFR within the first year after surgery, but still found strong discrimination both in the derivation [AUC of 0.81 (0.73e0.88)] and validation cohorts [0.89 (0.83e0.94)].
To assess a potential loss-to-follow-up bias, we fitted our logistic regression with calibration weighting and found no significant change in OR values (Supplementary Table S5 ).
Discussion
Here, we provide a score predicting the development of a CKD within the year after cardiac surgery. It uses the following variables: AKI stages according to the KDIGO criteria, age above 65 yr, preoperative eGFR below 80 ml min À1 (1.73 m)
À2
, aortic clamping time greater than 50 min, and type of surgery.
Most of the variables included in this score are already known to be associated with AKI. 2,21,22, 45e49 Surprisingly, we also found a very significant association between CKD and the use of norepinephrine during CPB. In a recent study, Lankadeva and colleagues 50 showed that, whereas norepinephrine improves renal function in a septic model by increasing the creatinine clearance and urine output, medullary oxygen tension and medullary perfusion were decreased. This may lead to secondary renal hypoxia injury and a subsequent decrease in renal function. Our study has several strengths. First, our score has been derived from a large cohort of 522 patients. Second, our score underwent an in-depth validation strategy. The internal validation performed by bootstrapping showed no deterioration in model discrimination or in the external validation using a second large cohort of 446 patients, sampled in another hospital. Third, discrimination was robust (c-statistic equal to 0.81) and fair (c-statistic equal to 0.78) in the derivation and validation cohorts, respectively. 51 Fourth, the score uses only six binary variables, all easily available and allowing for simple mental calculations by clinicians at the bedside. Fifth, changing the main outcome in a sensitivity analysis led to an increase in discrimination score capacity, enhancing the robustness of our results.
Our study has limitations. It is retrospective and we may not exclude the possibility of residual confounding factors (such as the use of drugs interfering with glomerular filtration, or subsequent AKI episodes) during the observation period. Nevertheless, our score was first internally validated using bootstrapping, and then externally validated in an independent and sufficiently large cohort to confirm the accuracy of prediction, with no significant difference between derivation and validation AUC (0.81 vs 0.78; P¼0.3). As in all retrospective studies, there is the issue of missing values. However, during the initial model selection, no variable had a missing value rate above 20%. We used multiple imputations to select the best model. In the final model, the residual missing value rate was less than 4%. The insufficient follow-up of patients reduced the inclusion rate and potentially introduces a selection bias, but this seems to be negligible, as an OR change between the weighted and unweighted logistic regressions is absent. The characteristics of excluded and included patients De novo chronic kidney disease (CKD) development after cardiac surgery: predicted risk, and observed risk in both derivation and validation cohorts for each score value. are presented in Supplementary Table S2 . Last, the French law demands 'colour-blind' data collection, which means that we did not apply the GFR-correcting factor for black patients, and were unable to measure the weight of ethnicity in the risk. The KDIGO Clinical Practice Guideline for Acute Kidney Injury recommends that all patients experiencing an AKI be referred to a nephrology specialist within 3 months. 26 Unfortunately, only a minority of these patients are indeed followed, 52 even though it is now well demonstrated that this strategy improves their mortality rates. 23 The routine use of our score could sensitise clinicians to the risk of CKD, not only after AKI, but also for the other associated risk factors highlighted by our study. Furthermore, knowledge of these newly identified risk factors could lead clinicians to adapt their daily practice to more long-term strategies.
